Radiogenomics Based on PET Imaging
- PMID: 32582396
- PMCID: PMC7295928
- DOI: 10.1007/s13139-020-00642-x
Radiogenomics Based on PET Imaging
Abstract
Radiogenomics or imaging genomics is a novel omics strategy of associating imaging data with genetic information, which has the potential to advance personalized medicine. Imaging features extracted from PET or PET/CT enable assessment of in vivo functional and physiological activity and provide comprehensive tumor information non-invasively. However, PET features are considered secondary to features on conventional imaging, and there has not yet been a review of the radiogenomic approach using PET features. This review article summarizes the current state of PET-based radiogenomic research for cancer, which discusses some of its limitations and directions for future study.
Keywords: Oncology; Positron emission tomography (PET); Radiogenomics.
© Korean Society of Nuclear Medicine 2020.
Conflict of interest statement
Conflict of InterestYong-Jin Park, Mu Heon Shin, and Seung Hwan Moon declare that they have no conflict of interest.
Figures
References
-
- Schillaci O, Urbano N. Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium. Eur J Nucl Med Mol Imaging. 2017;44:563–566. - PubMed
-
- Jaffe CC. Imaging and genomics: is there a synergy? Radiology. 2012;264:329–331. - PubMed
-
- Mazurowski MA. Radiogenomics: what it is and why it is important. J Am Coll Radiol. 2015;12:862–866. - PubMed
Publication types
LinkOut - more resources
Full Text Sources